Disclosures for "Neuromodulation with AI-Driven, Personalized Music-based Intervention to Reduce Anticipatory Anxiety Prior to Physician Examination: A Pilot Study"
-
-
Dr. Kaner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for United Therapeutics. Dr. Kaner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for boehringer ingelheim. Dr. Kaner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Verona Pharma. Dr. Kaner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PureTech. Dr. Kaner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pliant. Dr. Kaner has stock in Doximity. The institution of Dr. Kaner has received research support from NIH. The institution of Dr. Kaner has received research support from Boehringer Ingelheim. The institution of Dr. Kaner has received research support from Chiesi. The institution of Dr. Kaner has received research support from CSL Behring. The institution of Dr. Kaner has received research support from Bellerophon. The institution of Dr. Kaner has received research support from Toray. Dr. Kaner has received publishing royalties from a publication relating to health care.
-
-
-
Dr. Loftspring has nothing to disclose.
-
Dr. Wallace has stock in Neural Positive.